Israeli Startup Hopes to Battle Alzheimer’s

Israeli Startup Hopes to Battle Alzheimer’s

Credit:Arik Shraga

While the road ahead will be long, lab testing by Israeli researchers shows that an enzyme-inhibiting compound might slow down the progress of Alzheimer’s, reports the Times of Israel:

Israeli startup ProteKt Therapeutics is developing a drug to treat early stages of Alzheimer’s by targeting an enzyme that is believed to play a part in the development of the devastating neurodegenerative disease that causes memory loss and the inability to function.

The startup hopes that by inhibiting the enzyme, it will be able to bring about cognitive improvements in patients and slow the progress of the disease. It also hopes that the same treatment, when developed, could help with other neurodegenerative diseases such as ALS, Huntington and Parkinson’s.

Tags: Israeli Innovation

More From Fellowship Blog

Fellowship Blog

Faces of The Fellowship: Nina

For Nina, the monthly grocery card she receives from The Fellowship feels like “air to breathe.”

Fellowship Blog

Israeli Device Could Help Treat Coronavirus Patients in China

Dr. Eliezer Be'eri explains why an Israeli device used to treat pneumonia victims will offer coronavirus patients a safer treatment and will hopefully go on sale in China in the next few months.

Fellowship Blog

We Decided to Save Them

Grigori and Pran Tashchiyan survived the Armenian genocide, and sheltered and saved two Jewish children during the Holocaust.

Subscribe to our Newsletter

Stay informed about issues affecting Israel, the Jewish people, Jewish-Christian relations, receive daily devotionals, and more.